Po‐Han Lin

1.1k total citations
38 papers, 784 citations indexed

About

Po‐Han Lin is a scholar working on Oncology, Molecular Biology and Genetics. According to data from OpenAlex, Po‐Han Lin has authored 38 papers receiving a total of 784 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Oncology, 14 papers in Molecular Biology and 8 papers in Genetics. Recurrent topics in Po‐Han Lin's work include DNA Repair Mechanisms (8 papers), BRCA gene mutations in cancer (7 papers) and HER2/EGFR in Cancer Research (5 papers). Po‐Han Lin is often cited by papers focused on DNA Repair Mechanisms (8 papers), BRCA gene mutations in cancer (7 papers) and HER2/EGFR in Cancer Research (5 papers). Po‐Han Lin collaborates with scholars based in Taiwan, United States and France. Po‐Han Lin's co-authors include Yau‐Huei Wei, Shih-Huang Lee, Chiun‐Sheng Huang, Sung‐Hsin Kuo, Ching‐Hung Lin, Andrew Krivoshik, Tomasz M. Beer, Celestia S. Higano, Bertrand Tombal and Andrew J. Armstrong and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Scientific Reports.

In The Last Decade

Po‐Han Lin

36 papers receiving 777 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Po‐Han Lin Taiwan 17 273 263 219 208 135 38 784
Jacqueline Ming Liu Taiwan 15 192 0.7× 361 1.4× 165 0.8× 177 0.9× 112 0.8× 26 825
Babak Yazdani‐Biuki Austria 17 483 1.8× 292 1.1× 288 1.3× 155 0.7× 151 1.1× 26 950
Leszek Kozłowski Poland 12 256 0.9× 268 1.0× 154 0.7× 85 0.4× 75 0.6× 34 683
Mark Bandyk United States 13 413 1.5× 373 1.4× 125 0.6× 255 1.2× 81 0.6× 32 987
L.L. Miller United States 13 335 1.2× 332 1.3× 70 0.3× 229 1.1× 141 1.0× 30 900
Daria Arbogast United States 9 385 1.4× 483 1.8× 79 0.4× 149 0.7× 164 1.2× 9 1.2k
Hernan G. Vasquez United States 9 321 1.2× 215 0.8× 85 0.4× 194 0.9× 50 0.4× 15 820
Frédéric Commo France 13 247 0.9× 273 1.0× 171 0.8× 226 1.1× 53 0.4× 16 774
Kwang‐Sun Suh South Korea 15 235 0.9× 183 0.7× 235 1.1× 105 0.5× 40 0.3× 55 802
Kathleen M. Woods Ignatoski United States 19 420 1.5× 291 1.1× 126 0.6× 109 0.5× 93 0.7× 30 858

Countries citing papers authored by Po‐Han Lin

Since Specialization
Citations

This map shows the geographic impact of Po‐Han Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Po‐Han Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Po‐Han Lin more than expected).

Fields of papers citing papers by Po‐Han Lin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Po‐Han Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Po‐Han Lin. The network helps show where Po‐Han Lin may publish in the future.

Co-authorship network of co-authors of Po‐Han Lin

This figure shows the co-authorship network connecting the top 25 collaborators of Po‐Han Lin. A scholar is included among the top collaborators of Po‐Han Lin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Po‐Han Lin. Po‐Han Lin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chiang, Ying‐Cheng, et al.. (2025). Whole exome sequencing-based homologous recombination deficiency test for epithelial ovarian cancer. Journal of Ovarian Research. 18(1). 19–19.
2.
3.
4.
Lin, Po‐Han, Yu‐Wen Tien, Wen‐Fang Cheng, et al.. (2023). Diverse genetic spectrum among patients who met the criteria of hereditary breast, ovarian and pancreatic cancer syndrome. Journal of Gynecologic Oncology. 34(5). e66–e66. 2 indexed citations
5.
Lee, Chih‐Ying, Wen‐Fang Cheng, Po‐Han Lin, et al.. (2023). An activity-based functional test for identifying homologous recombination deficiencies across cancer types in real time. Cell Reports Medicine. 4(11). 101247–101247. 5 indexed citations
6.
Lin, Po‐Han, Ling‐Ming Tseng, Yi‐Hsuan Lee, et al.. (2022). Neoadjuvant afatinib with paclitaxel for triple-negative breast cancer and the molecular characteristics in responders and non-responders. Journal of the Formosan Medical Association. 121(12). 2538–2547. 11 indexed citations
7.
Wu, Hui‐Chen, Hwai‐I Yang, Po‐Han Lin, et al.. (2021). Reproductive and environmental exposures and the breast cancer risk in Taiwanese women. Scientific Reports. 11(1). 15656–15656. 3 indexed citations
8.
Chiang, Ying‐Cheng, Po‐Han Lin, & Wen‐Fang Cheng. (2021). Homologous Recombination Deficiency Assays in Epithelial Ovarian Cancer: Current Status and Future Direction. Frontiers in Oncology. 11. 675972–675972. 22 indexed citations
9.
Lin, Po‐Han, Ming Chen, Chiao Lo, et al.. (2020). Using next‐generation sequencing to redefineBRCAnessin triple‐negative breast cancer. Cancer Science. 111(4). 1375–1384. 31 indexed citations
10.
Lin, Po‐Han, et al.. (2020). Regulation of extracellular and intracellular prolactin on cell proliferation and survival rate through GHR/JAK2/STAT3 pathway in NSCLC. Chemosphere. 264(Pt 1). 128604–128604. 8 indexed citations
11.
Armstrong, Andrew J., Po‐Han Lin, Celestia S. Higano, et al.. (2018). Development and validation of a prognostic model for overall survival in chemotherapy-naïve men with metastatic castration-resistant prostate cancer. Annals of Oncology. 29(11). 2200–2207. 49 indexed citations
12.
Bryce, Alan H., Joshi J. Alumkal, Andrew J. Armstrong, et al.. (2017). Radiographic progression with nonrising PSA in metastatic castration-resistant prostate cancer: post hoc analysis of PREVAIL. Prostate Cancer and Prostatic Diseases. 20(2). 221–227. 71 indexed citations
13.
Hsu, Chia‐Chi, Chia‐Han Lee, Tzu‐Ting Huang, et al.. (2017). Combination of palbociclib with enzalutamide shows in vitro activity in RB proficient and androgen receptor positive triple negative breast cancer cells. PLoS ONE. 12(12). e0189007–e0189007. 49 indexed citations
14.
Chou, Wen‐Chi, Po‐Han Lin, Yi‐Chen Yeh, et al.. (2016). Genes involved in angiogenesis and mTOR pathways are frequently mutated in Asian patients with pancreatic neuroendocrine tumors. International Journal of Biological Sciences. 12(12). 1523–1532. 23 indexed citations
15.
Bai, Li-Yuan, Jing‐Ru Weng, Chang-Fang Chiu, et al.. (2013). OSU-A9, an indole-3-carbinol derivative, induces cytotoxicity in acute myeloid leukemia through reactive oxygen species-mediated apoptosis. Biochemical Pharmacology. 86(10). 1430–1440. 25 indexed citations
16.
Lin, Po‐Han, Ming‐Hsin Yeh, Liang‐Chih Liu, et al.. (2013). Clinical and pathologic risk factors of tumor recurrence in patients with node-negative early breast cancer after mastectomy. Journal of Surgical Oncology. 108(6). 352–357. 12 indexed citations
17.
Lin, Po‐Han, Ching‐Chan Lin, Hwai‐I Yang, et al.. (2012). Prognostic impact of allogeneic hematopoietic stem cell transplantation for acute myeloid leukemia patients with internal tandem duplication of FLT3. Leukemia Research. 37(3). 287–292. 34 indexed citations
18.
Lin, Po‐Han, et al.. (2011). Cisplatin as an active treatment in zoledronate-refractory hypercalcemia. Annals of Oncology. 22(5). 1244–1246. 1 indexed citations
19.
Lien, Han‐Chung, Cheng‐Chi Wang, Jeng‐Yuan Hsu, et al.. (2010). Classical reflux symptoms, hiatus hernia and overweight independently predict pharyngeal acid exposure in patients with suspected reflux laryngitis. Alimentary Pharmacology & Therapeutics. 33(1). 89–98. 15 indexed citations
20.
Lin, Po‐Han, et al.. (2003). Oxidative damage to mitochondrial DNA in atrial muscle of patients with atrial fibrillation. Free Radical Biology and Medicine. 35(10). 1310–1318. 120 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jacqueline Ming Liu Breakdown of academic impact, for papers by Babak Yazdani‐Biuki Breakdown of academic impact, for papers by Leszek Kozłowski Breakdown of academic impact, for papers by Mark Bandyk Breakdown of academic impact, for papers by L.L. Miller Breakdown of academic impact, for papers by Daria Arbogast Breakdown of academic impact, for papers by Hernan G. Vasquez Breakdown of academic impact, for papers by Frédéric Commo Breakdown of academic impact, for papers by Kwang‐Sun Suh Breakdown of academic impact, for papers by Kathleen M. Woods Ignatoski
Rankless by CCL
2026